- Home
- SCYX vs PODC Comparison
SCYX vs PODC Comparison
Compare SCYX & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- PODC
- Stock Information
- Founded
- SCYX 1999
- PODC 2013
- Country
- SCYX United States
- PODC United States
- Employees
- SCYX N/A
- PODC N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- PODC
- Sector
- SCYX Health Care
- PODC
- Exchange
- SCYX Nasdaq
- PODC Nasdaq
- Market Cap
- SCYX 40.9M
- PODC 44.1M
- IPO Year
- SCYX 2014
- PODC N/A
- Fundamental
- Price
- SCYX $1.03
- PODC $1.40
- Analyst Decision
- SCYX Buy
- PODC Strong Buy
- Analyst Count
- SCYX 1
- PODC 1
- Target Price
- SCYX N/A
- PODC $5.00
- AVG Volume (30 Days)
- SCYX 135.5K
- PODC 26.0K
- Earning Date
- SCYX 03-12-2025
- PODC 02-12-2025
- Dividend Yield
- SCYX N/A
- PODC N/A
- EPS Growth
- SCYX N/A
- PODC N/A
- EPS
- SCYX N/A
- PODC N/A
- Revenue
- SCYX $3,746,000.00
- PODC $49,729,000.00
- Revenue This Year
- SCYX $1,541.00
- PODC $20.42
- Revenue Next Year
- SCYX $111.43
- PODC $18.84
- P/E Ratio
- SCYX N/A
- PODC N/A
- Revenue Growth
- SCYX N/A
- PODC 22.98
- 52 Week Low
- SCYX $0.82
- PODC $1.10
- 52 Week High
- SCYX $3.07
- PODC $2.85
- Technical
- Relative Strength Index (RSI)
- SCYX 50.55
- PODC 38.39
- Support Level
- SCYX $1.00
- PODC $1.36
- Resistance Level
- SCYX $1.06
- PODC $1.81
- Average True Range (ATR)
- SCYX 0.07
- PODC 0.17
- MACD
- SCYX 0.02
- PODC -0.00
- Stochastic Oscillator
- SCYX 63.30
- PODC 25.93
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.